We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Cancer Invasion Identified with Surgical Fluorescence Technique

By HospiMedica International staff writers
Posted on 22 Jan 2013
A new study describes a technique that will allow intraoperative detection of lymph node cancer metastases, so that healthy tissue can be preserved.

Researchers at the University of California, San Diego (UCSD; USA) have developed injectable fluorescently labeled molecules, which have been termed ratiometric activatable cell-penetrating peptides (RACPP). More...
When used in mouse models, the peptides allowed surgeons to see where the cancer had spread with high sensitivity and specificity, even when the metastatic sites were only a few millimeters in size. The new technique could decrease time under anesthesia, since the surgical team need not wait for pathology reports, as well reducing unnecessary surgery on noncancerous lymph nodes.

This form of “instant pathology” is an important improvement over traditional sentinel node mapping, whereby only the location of the lymph node is detected, without gleaning any information on actual cancer involvement. Additionally, current methods for managing prostate cancer and neck squamous cell carcinoma, for example, only reveal the extent of cancer involvement after the patient has undergone surgical removal of all susceptible lymph nodes. The study was published in the January 15, 2012, issue of Cancer Research.

“With molecular-targeted imaging, surgeons can avoid unnecessary removal of healthy lymph nodes which is better long-term for patients,” said lead author associate Professor Quyen T. Nguyen, MD, PhD, director of the facial nerve clinic at UCSD Health System. “The range of the surgeon's visual field is greatly enhanced by a molecular tool that can help achieve accurate surgical margins and detection of metastases so that no tumor is left behind.”

Lymph nodes, located throughout the body, serve as biologic filters that contain immune cells to fight infection and clean the blood. When cancer cells break away from a tumor, the cells can travel through the lymph system; sentinel node surgery allows the surgeon to remove the nodes to determine cancer spread. Human nodes, however, are only half a centimeter in size, and are difficult to discern among the surrounding tissue during surgery. Furthermore, even when surgeons are able to map the location of the nodes, there is no current technique that indicates whether the lymph nodes contain cancer, requiring removal of more lymph nodes than necessary.

Related Links:
University of California, San Diego


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.